Peter Andersen

Peter Andersen

Professor


Publication year:
All
1 - 3 out of 3Page size: 10
  1. 2021
  2. Published

    In vivo antigen expression regulates cd4 t cell differentiation and vaccine efficacy against mycobacterium tuberculosis infection

    Clemmensen, H. S., Dube, J. Y., McIntosh, F., Rosenkrands, I., Jungersen, G., Aagaard, C., Andersen, Peter, Behr, M. A. & Mortensen, R., 2021, In: mBio. 12, 2, 16 p., e00226-21.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    A Chlamydia trachomatis VD1-MOMP vaccine elicits cross-neutralizing and protective antibodies against C/C-related complex serovars: [Inkl. correction]

    Olsen, A. W., Rosenkrands, I., Holland, M. J., Andersen, Peter & Follmann, F., 2021, In: npj Vaccines. 6, 1, 11 p., 58.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    A Mycobacterium tuberculosis-specific subunit vaccine that provides synergistic immunity upon co-administration with Bacillus Calmette-Guérin

    Woodworth, J. S., Clemmensen, H. S., Battey, H., Dijkman, K., Lindenstrøm, T., Laureano, R. S., Taplitz, R., Morgan, J., Aagaard, C., Rosenkrands, I., Lindestam Arlehamn, C. S., Andersen, Peter & Mortensen, R., 2021, In: Nature Communications. 12, 13 p., 6658.

    Research output: Contribution to journal › Journal article › Research › peer-review

ID: 212552530